Food News and Research

RSS

Best Practices report: 50% of participating companies fail collect AE reports from Internet sources

Drug safety remains front and center for the U.S. Food and Drug Administration as the agency strives to improve the public's perception of the organization. Likewise, the pharmaceutical industry is focused on improving its reputation among consumers and recognizes that its diligence in the reporting of adverse events plays an important role in that effort.

29 Jan 2011

OCPS unveils new school recipes at Chefs Move to Schools event

Orange County Public Schools, the tenth largest school district in the country, unveiled new school recipes that are "chef-inspired, kid-approved" in partnership with America's top chefs representing the leading culinary associations in the United States at the Chefs Move to Schools event in Orlando, Florida.

29 Jan 2011

Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

International philanthropists are challenging the world to provide a Cancer Research Project offering the most efficient solution in Particle Physics for early cancer detection with the highest potential to reduce premature cancer death.

29 Jan 2011

PPTA offers new DVD on plasma donation

Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new DVD from the Plasma Protein Therapeutics Association.

29 Jan 2011

ISU researchers study parasites that cause NTDs in humans

Richard Martin, DVM, PhD, a biomedical sciences professor at Iowa State University's College of Veterinary Medicine, has devoted his 35-year career to studying nematode parasites. These parasites infect approximately one-quarter of the world population, producing debilitating symptoms that devastate the lives and economies of many of the world's underdeveloped and impoverished areas.

29 Jan 2011

FDA reports possible association between breast implants, ALCL

The U.S. Food and Drug Administration reported on January 26 that "a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer. Data reviewed by the FDA suggests that patients with breast implants may have a very small, but significant risk, of ALCL in the scar capsule adjacent to the implant.

29 Jan 2011

Adeona to sell 2.85 million common stock at $1.40 per share

Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.

29 Jan 2011

U-M researchers reveal molecular signals that regulate catch-up growth

University of Michigan researchers have uncovered molecular signals that regulate catch-up growth---the growth spurt that occurs when normal conditions are restored after a fetus, young animal or child has been ill, under stress or deprived of enough food or oxygen to grow properly.

29 Jan 2011

King Pharmaceuticals awards payment to Pain Therapeutics for abuse-resistant medications

Pain Therapeutics, today announced that it had received a $5,000,000 milestone payment from King Pharmaceuticals, its exclusive commercial partner for abuse-resistant prescription pain medications.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

Clinton, other speakers discuss poverty, development issues at World Economic Forum

"Poverty and unemployment reared their heads at the World Economic Forum on Thursday, with speakers urging the elite audience to bridge a growing gap between booming multinationals and the jobless poor," Reuters reports.

29 Jan 2011

Synutra International renews manufacturing license for its primary production facility

Synutra International, Inc., a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced that it has renewed its manufacturing license for its primary production facility with the Shandong Bureau of Quality and Technical Supervision.

29 Jan 2011

New feature: KHN's selection of thought-provoking magazine articles on health policy issues

Today, we begin this new weekly feature, which will provide a selection of thought-provoking articles from a variety of sources.

29 Jan 2011

FDA approves Mylan's ANDA for ER Tablets

Mylan today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nisoldipine Extended-release Tablets, 8.5 mg, 17 mg, 25.5 mg and 34 mg.

29 Jan 2011

Exposure to infections in early childhood can protect child from eczema later in life: Study

Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed that treating a pregnant woman for worm infections increased her child's chances of developing the allergic skin disease.

29 Jan 2011

European Commission to implement SUNRAY-project to tackle malnutrition in Africa

The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.

28 Jan 2011

Genentech, Biogen announce FDA approval of Rituxan to treat follicular lymphoma

Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.

28 Jan 2011

WOUNDS article profiles efficacy of Quick-Med's antimicrobial BIOGUARD dressings

Quick-Med Technologies, Inc. announced today that the February 2011 issue of WOUNDS, the leading peer-reviewed journal in the wound care field, will feature an article authored by Quick-Med's Albina Mikhaylova, PhD. The article profiles the safety and antimicrobial efficacy of cutting edge antimicrobial dressings employing Quick-Med's patented NIMBUS technology and marketed by Derma Sciences, Inc. under its BIOGUARD® trademark.

28 Jan 2011

Survey finds public lack knowledge of radiotherapy

Fewer than one in ten people think radiotherapy is a modern cancer treatment according to the results of a survey published Friday.

28 Jan 2011

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

28 Jan 2011

Food News and Research

Best Practices report: 50% of participating companies fail collect AE reports from Internet sources

OCPS unveils new school recipes at Chefs Move to Schools event

Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

PPTA offers new DVD on plasma donation

ISU researchers study parasites that cause NTDs in humans

FDA reports possible association between breast implants, ALCL

Adeona to sell 2.85 million common stock at $1.40 per share

U-M researchers reveal molecular signals that regulate catch-up growth

King Pharmaceuticals awards payment to Pain Therapeutics for abuse-resistant medications

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Clinton, other speakers discuss poverty, development issues at World Economic Forum

Synutra International renews manufacturing license for its primary production facility

New feature: KHN's selection of thought-provoking magazine articles on health policy issues

FDA approves Mylan's ANDA for ER Tablets

Exposure to infections in early childhood can protect child from eczema later in life: Study

European Commission to implement SUNRAY-project to tackle malnutrition in Africa

Genentech, Biogen announce FDA approval of Rituxan to treat follicular lymphoma

WOUNDS article profiles efficacy of Quick-Med's antimicrobial BIOGUARD dressings

Survey finds public lack knowledge of radiotherapy

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Enhancing confidence in chemical ionization spectrometry data eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News